| View |
|
DRP-14606-02
|
Apixaban
|
Elixaban
|
5 mg
|
Film-Coated Tablet
|
Anti-thrombotic Agent (Direct Factor Xa Inhibitor)
|
Baroque Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 August 2024
|
27 October 2028
|
| View |
|
DRP-14654-01
|
Captopril
|
Captophil
|
25 mg
|
Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
04 August 2024
|
17 April 2029
|
| View |
|
DRP-14660-01
|
Multivitamins
|
Juliavit
|
(see reverse for formulation)
|
Capsule
|
Vitamin
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
06 August 2024
|
17 November 2028
|
| View |
|
DRP-14776-05
|
Norepinephrine (as bitartrate)
|
Nupira
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic/ Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
03 August 2024
|
03 January 2029
|
| View |
|
DRP-14960-01
|
Paracetamol
|
Elpara
|
10 mg/mL (500 mg/50 mL) and (1g/100 mL )
|
Solution for Injection (IV Infusion)
|
Analgesic/Antipyretic (Anilide)
|
Hebei Tiancheng Pharmaceutical Co.,Ltd
|
China
|
CLIDP Conversion
|
04 August 2024
|
27 February 2029
|
| View |
|
DRP-15073-01
|
Methotrexate
|
Kemotrexate
|
2.5 mg
|
Tablet
|
Antineoplastic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
25 July 2024
|
12 April 2029
|
| View |
|
DRP-15093-01
|
Rosuvastatin (as Calcium)
|
Lipiruvin
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 August 2024
|
23 April 2029
|
| View |
|
DRP-15093-02
|
Rosuvastatin (as Calcium)
|
Cholsuvin
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 August 2024
|
23 April 2029
|
| View |
|
DRP-15101-01
|
Terazosin (as Hydrochloride)
|
Hytrin®
|
2 mg
|
Tablet
|
Alpha-adrenoreceptor Antagonist
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
04 August 2024
|
06 April 2025
|
| View |
|
DRP-15183-01
|
Co-Amoxiclav
|
Raniclav-DS
|
1 g
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
GIYAAN PHARMA PRIVATE LIMITED
|
India
|
CLIDP Conversion
|
04 August 2024
|
21 May 2029
|
| View |
|
DRP-15285-01
|
Valsartan + Amlodipine (as besilate)
|
Amlovart 160/5
|
160 mg /5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium Channel Blocker
|
Humanis Saglik Anonim Sirketi
|
Turkey
|
CLIDP Conversion
|
06 August 2024
|
06 June 2029
|
| View |
|
DRP-176-14
|
Multivitamins + Iron
|
Mintrovit OB
|
|
Capsule
|
Vitamins / Mineral
|
Scheele Laboratories Phils., Inc.
|
India
|
CLIDP Conversion
|
25 July 2024
|
14 April 2028
|
| View |
|
DRP-2254-05
|
Atorvastatin (as calcium)
|
Atorseth 40
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 August 2024
|
09 June 2025
|
| View |
|
DRP-2653-22
|
Buclizine Hydrochloride + Vitamin B Complex + Iron
|
Appefer-S
|
(see reverse)
|
Capsule
|
Vitamins and Mineral
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
06 August 2024
|
11 March 2029
|
| View |
|
DRP-2797-05
|
Mometasone Furoate
|
Melia
|
1 mg/g (0.1% w/w)
|
Cream
|
Corticosteroid
|
Agio Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
22 July 2024
|
03 September 2026
|
| View |
|
DRP-290-05
|
Ceftriaxone (as Sodium)
|
Eftrix
|
1g
|
Powder for Injection(IM/IV)
|
Antibacterial (Cephalosporin)
|
Shin Poong Pharmaceutical Co., Ltd
|
Korea
|
CLIDP Conversion
|
03 August 2024
|
11 April 2026
|
| View |
|
DRP-3248-08
|
Azithromycin (as dihydrate)
|
Retamycin
|
200 mg/5 mL
|
Granules for Oral Suspension
|
Antibacterial (Macrolide)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 August 2024
|
20 September 2026
|
| View |
|
DRP-3555-03
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Piptazoden
|
4 g/500 mg
|
Powder for Injection (I.V.)
|
Antibacterial
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
25 July 2024
|
26 August 2029
|
| View |
|
DRP-3599-03
|
Phenylpropanolamine Hydrochloride + Chlorpheniramine Maleate
|
Flukid
|
1.0mg/ 0.8mg per mL
|
Syrup (Oral Drops)
|
Nasal Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
06 August 2024
|
28 December 2026
|
| View |
|
DRP-4115-02
|
Aluminum Hydroxide + Magnesium Hydroxide
|
Ducid Chews
|
200 mg/100 mg
|
Chewable Tablet
|
Antacid
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 August 2024
|
23 November 2027
|